![1]()
News
Risk factors for postop cardiac events differ between vascular and general surgery
September 14, 2018
Predictive risk factors for cardiac events after general and vascular surgery differed significantly.
![1]()
News
New stroke intervention guidelines stress volume
September 12, 2018
New guidelines set minimum procedures per year for level 1 and level 2 stroke centers, but leave some wiggle room for centers in underserved regions.
![1]()
News
Pregnancy boosts cardiac disease mortality nearly 100-fold
September 12, 2018
MUNICH – Registry data from more than 5,700 women with cardiac disease who became pregnant provide insight on complication rates.
![1]()
News
Coronary CT angiography radiation dose fell 78% from 2007-2017
September 11, 2018
MUNICH – A 2017 survey of coronary CT angiography radiation doses for 4,502 patients at 61 worldwide sites showed a 78% drop compared with 2007.
![1]()
News
Danish endocarditis strategy halved hospital days
September 10, 2018
MUNICH – POET trial shows early discharge after switch from intravenous to oral antibiotics is safe and effective.
![1]()
News
Rivaroxaban superior to aspirin for extended VTE treatment
August 29, 2018
Researchers said there is no longer a place for aspirin in extended VTE treatment.
News
Declining lung function linked to heart failure, stroke
August 28, 2018
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease detection.
![1]()
News
New MI definition aims to better distinguish infarction from injury
August 28, 2018
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S. practice.
News
Rivaroxaban no help for heart failure outcomes
August 27, 2018
MUNICH - Rivaroxaban did not change outcome in patients with heart failure and coronary artery disease in the COMMANDER trial.
News
VTE risk unchanged by rivaroxaban after discharge
August 26, 2018
The MARINER study looked at postdischarge rivaroxaban in individuals who had been recently hospitalized and were at an increased risk of venous thromboembolism.
